Funding Round attributes
Biological Lattice Industries (BLI), a company focused on advancing biofabrication technology, has announced the successful closure of a $1.8 million pre-seed funding round. This investment, led by Uni.Fund, aims to enhance BLI's capabilities in democratizing biofabrication, which is an emerging field that combines biology and engineering to produce biological materials.
Founded with a vision to make biofabrication accessible, BLI seeks to innovate the way biological materials are created and utilized. The funding secured will play a critical role in accelerating the company's research and development efforts, enabling it to refine its technologies and expand its market reach. Biofabrication has gained traction in recent years due to its potential applications in areas such as medicine, materials science, and sustainability.
